SI20057A - Vodna suspenzija za intranazalno uporabo - Google Patents

Vodna suspenzija za intranazalno uporabo Download PDF

Info

Publication number
SI20057A
SI20057A SI9820018A SI9820018A SI20057A SI 20057 A SI20057 A SI 20057A SI 9820018 A SI9820018 A SI 9820018A SI 9820018 A SI9820018 A SI 9820018A SI 20057 A SI20057 A SI 20057A
Authority
SI
Slovenia
Prior art keywords
aqueous suspension
suspension
loteprednol etabonate
mixture
microcrystalline cellulose
Prior art date
Application number
SI9820018A
Other languages
English (en)
Slovenian (sl)
Inventor
Koji Doi
Original Assignee
Bodor Nicholas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bodor Nicholas filed Critical Bodor Nicholas
Publication of SI20057A publication Critical patent/SI20057A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SI9820018A 1997-01-16 1998-01-14 Vodna suspenzija za intranazalno uporabo SI20057A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1966497 1997-01-16
PCT/JP1998/000108 WO1998031343A2 (fr) 1997-01-16 1998-01-14 Suspension aqueuse pour administration nasale

Publications (1)

Publication Number Publication Date
SI20057A true SI20057A (sl) 2000-04-30

Family

ID=12005518

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9820018A SI20057A (sl) 1997-01-16 1998-01-14 Vodna suspenzija za intranazalno uporabo

Country Status (33)

Country Link
US (1) US6368616B1 (fr)
EP (1) EP0973501B1 (fr)
KR (1) KR100471708B1 (fr)
CN (1) CN1126535C (fr)
AR (1) AR011773A1 (fr)
AT (1) ATE249205T1 (fr)
AU (1) AU730953C (fr)
BR (1) BR9806771A (fr)
CA (1) CA2278025C (fr)
CZ (1) CZ294919B6 (fr)
DE (1) DE69818026T2 (fr)
DK (1) DK0973501T3 (fr)
EA (1) EA001775B1 (fr)
ES (1) ES2206880T3 (fr)
HK (1) HK1026138A1 (fr)
HU (1) HU226613B1 (fr)
ID (1) ID21892A (fr)
IL (1) IL130979A0 (fr)
LT (1) LT4677B (fr)
LV (1) LV12449B (fr)
MX (1) MXPA99006628A (fr)
NO (1) NO324619B1 (fr)
NZ (2) NZ509908A (fr)
PL (1) PL190753B1 (fr)
PT (1) PT973501E (fr)
RS (1) RS49701B (fr)
SI (1) SI20057A (fr)
SK (1) SK283164B6 (fr)
TR (1) TR199901663T2 (fr)
TW (1) TW503113B (fr)
UA (1) UA52722C2 (fr)
WO (1) WO1998031343A2 (fr)
ZA (1) ZA98303B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
ES2263282T3 (es) * 1998-08-26 2006-12-01 Teijin Limited Composiciones en polvo para administracion nasal.
DE19947235A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US6565832B1 (en) * 2000-01-31 2003-05-20 Schering-Plough Healthcare Products, Inc. Spray composition with reduced dripping
IL159415A0 (en) * 2001-06-18 2004-06-01 Noven Pharma Enhanced drug delivery in transdermal systems
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7419971B2 (en) * 2003-06-19 2008-09-02 Bodor Nicholas S Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
ES2339351T3 (es) 2003-06-19 2010-05-19 Nicholas S. Bodor Mejora de la actividad y/o duracion de la accion de esteroides anti-inflamatorios blandos para la aplicacion topica u otra local.
US20050095205A1 (en) * 2003-10-31 2005-05-05 Ramesh Krishnamoorthy Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
ES2330762T3 (es) 2004-03-25 2009-12-15 BAUSCH & LOMB INCORPORATED Uso de etabonato de loteprednol para el tratamiento del ojo seco.
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
WO2007058935A2 (fr) * 2005-11-14 2007-05-24 Bausch & Lomb Incorporated Composition ophtalmique pour le traitement de l'oeil sec
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
WO2012119261A1 (fr) * 2011-03-10 2012-09-13 Biocia Inc. Composition de mucus artificiel améliorée comprenant du hyaluronane pour le traitement de la rhinite
AU2012312816A1 (en) 2011-09-22 2014-04-24 Bausch & Lomb Incorporated Ophthalmic gel compositions
AR112480A1 (es) 2017-08-24 2019-10-30 Novo Nordisk As Composiciones de glp-1 y sus usos
US20230093542A1 (en) 2020-02-18 2023-03-23 Novo Nordisk A/S Glp-1 compositions and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
EP0709099A3 (fr) * 1994-09-28 1996-07-24 Senju Pharma Co Suspension aqueuse nasale comprenant cyclodextrine
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액

Also Published As

Publication number Publication date
WO1998031343A2 (fr) 1998-07-23
WO1998031343A3 (fr) 1998-09-17
AU730953C (en) 2002-02-07
PL190753B1 (pl) 2006-01-31
NO324619B1 (no) 2007-11-26
CN1250370A (zh) 2000-04-12
DE69818026T2 (de) 2004-07-08
BR9806771A (pt) 2000-05-16
DK0973501T3 (da) 2004-01-19
KR100471708B1 (ko) 2005-03-07
LV12449A (lv) 2000-04-20
ID21892A (id) 1999-08-05
EA199900659A1 (ru) 2000-02-28
ES2206880T3 (es) 2004-05-16
PL334614A1 (en) 2000-03-13
KR20000070214A (ko) 2000-11-25
CZ237499A3 (cs) 2000-01-12
ATE249205T1 (de) 2003-09-15
ZA98303B (en) 1998-07-20
HUP0002473A2 (hu) 2000-12-28
NO993453D0 (no) 1999-07-13
RS49701B (sr) 2007-12-31
PT973501E (pt) 2004-02-27
NZ336990A (en) 2001-03-30
EA001775B1 (ru) 2001-08-27
CZ294919B6 (cs) 2005-04-13
NZ509908A (en) 2004-12-24
IL130979A0 (en) 2001-01-28
LT4677B (lt) 2000-07-25
SK94899A3 (en) 2000-05-16
SK283164B6 (sk) 2003-03-04
EP0973501B1 (fr) 2003-09-10
TW503113B (en) 2002-09-21
CN1126535C (zh) 2003-11-05
CA2278025A1 (fr) 1998-07-23
LT99100A (en) 2000-02-25
HU226613B1 (en) 2009-04-28
LV12449B (en) 2000-09-20
AU730953B2 (en) 2001-03-22
AR011773A1 (es) 2000-09-13
HK1026138A1 (en) 2000-12-08
TR199901663T2 (xx) 1999-09-21
DE69818026D1 (de) 2003-10-16
NO993453L (no) 1999-07-13
UA52722C2 (uk) 2003-01-15
HUP0002473A3 (en) 2001-01-29
EP0973501A2 (fr) 2000-01-26
MXPA99006628A (es) 2005-01-10
AU5495298A (en) 1998-08-07
YU36199A (sh) 2002-09-19
US6368616B1 (en) 2002-04-09
CA2278025C (fr) 2005-09-06

Similar Documents

Publication Publication Date Title
SI20057A (sl) Vodna suspenzija za intranazalno uporabo
US6458842B1 (en) Liquid pharmaceutical compositions comprising thyroid hormones
EP0709099A2 (fr) Suspension aqueuse nasale comprenant cyclodextrine
JP6934581B2 (ja) エピナスチン又はその塩を含有する水性医薬組成物
EP3593788B1 (fr) Compositions ophtalmiques contenant un prostamide libérant de l'oxyde nitrique
US20220370445A1 (en) Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide
EP3737378B1 (fr) Collyre palonosétron destiné au traitement ou la prévention de nausées et vomissements
JPH08151332A (ja) 点鼻用水性懸濁液
JP4453987B2 (ja) 点鼻用水性懸濁液
WO2024034592A1 (fr) Composition pharmaceutique aqueuse contenant de l'udca ou un sel de celui-ci
CN102264344A (zh) 递送有效浓度的活性剂至眼睛后段的局部眼用溶液组合物
JP2022001606A (ja) エピナスチン又はその塩を含有する水性組成物

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20100820